RECRUITING

Wellness, Intervention Strategies and HIV Care

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a pilot trial designed to assess the feasibility and acceptability of an intervention aimed at improving adherence to antiretroviral therapy (ART), viral suppression, and engagement in HIV care. The intervention will address behavioral coping strategies, HIV care engagement behaviors, and substance use management.

Official Title

Wellness, Intervention Strategies and HIV Care

Quick Facts

Study Start:2025-07-14
Study Completion:2026-03-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07069374

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Be at least 18 years of age
  2. * Self-report biological characteristics consistent with the population under study
  3. * Be HIV-positive
  4. * Report use of at least one of the following substances in the last 90 days:
  5. * Cannabis
  6. * Methamphetamine
  7. * Cocaine/crack
  8. * Cocaine
  9. * Heroin
  10. * Non-prescribed opioids (e.g., fentanyl, morphine)
  11. * Ecstasy
  12. * Phencyclidine (PCP)
  13. * Psychedelics (e.g., Lysergic acid diethylamide, mescaline, ketamine)
  14. * Poppers (alkyl nitrites)
  15. * Non-prescribed benzodiazepines (e.g., Valium, Xanax, Klonopin, Librium)
  16. * Barbiturates
  17. * Be English-speaking
  18. * Be able and willing to provide informed consent
  1. * Evidence of severe cognitive impairment or active psychosis that may impede ability to provide fully informed consent, determined by the research assistants and clinical supervisor(s)
  2. * The research staff are trained on guidelines for identifying participants who exhibit signs of inability to meaningfully participate or provide consent due to mental illness or impairment

Contacts and Locations

Study Contact

Heather Freasier Project Director, MS
CONTACT
415-502-8800
heather.freasier@ucsf.edu
Julian Paredes-Gotamco Clinical Research Coordinator
CONTACT
415-502-3507
Julian.Paredes-Gotamco@ucsf.edu

Principal Investigator

Jennifer P Jain, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

Oakland MWCCS Site Office
Oakland, California, 94612
United States
SF MWCCS Site Office
San Francisco, California, 94115
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Jennifer P Jain, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-14
Study Completion Date2026-03-30

Study Record Updates

Study Start Date2025-07-14
Study Completion Date2026-03-30

Terms related to this study

Keywords Provided by Researchers

  • HIV
  • Substance Use
  • Risk Reduction
  • Behavioral Intervention
  • Public Health
  • Intervention Program

Additional Relevant MeSH Terms

  • HIV
  • Substance Use Disorder (SUD)